Treatment of Acute Myeloblastic Leukemia in Younger Patients

Status:
Completed

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

study of the value of the cytogenetics and the monitoring of the residual minimum disease in the standard treatment of acute myeloblastic leukemia.

PETHEMA Foundation